Open: 0.0 Close: 0.0 Change: 0.0

Today's Summary

Saturn V Capital Management LP raised its stake in Dyne Therapeutics by about 1.2 million shares compared to the prior quarter. the funds position in Dynes Therapeutics is now valued at $33.8 million.Saturn V Capital Management LP increased its stake in Dyne Therapeutics by about 1.2 million shares compared to the prior quarter. the funds position in Dynes Therapeutics is now valued at $33.8 million.Dyne plans to allow participants currently in screening to enroll if they meet all eligibility criteria. as a result, the REC expects to complete enrollment of more than 60 participants in Q2 2026.